Tevogen Bio Holdings (TVGN) Amortizatization of Intangibles (2023 - 2026)
Tevogen Bio Holdings (TVGN) reported Amortizatization of Intangibles of $28783.0 for Q1 2026, down 55.62% on a YoY basis from $64849.0 in Q1 2025, and up 3.82% quarter-over-quarter from $27725.0 in Q4 2025.
Tevogen Bio Holdings (TVGN) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Amortizatization of Intangibles for 4 years, with the latest figure at $28783.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 55.62% year-over-year to $28783.0; the trailing twelve-month figure through Mar 2026 stood at $282558.0 (up 13.72% YoY), and the FY2025 full-year result was $318624.0, up 32.01% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $28783.0, up from $27725.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $199343.0 in Q2 2025, with the low at $26707.0 in Q3 2025.
- Historically, Amortizatization of Intangibles has averaged $61833.5 across 4 years, with a median of $56775.0 in 2023.
- The largest YoY upside for Amortizatization of Intangibles was 235.38% in 2025 against a maximum downside of 56.35% in 2025.
- Tevogen Bio Holdings' Amortizatization of Intangibles stood at $56775.0 in 2023, then gained by 10.96% to $62995.0 in 2024, then plunged by 55.99% to $27725.0 in 2025, then gained by 3.82% to $28783.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $28783.0 (Q1 2026), $27725.0 (Q4 2025), and $26707.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | 28,783.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,783.00 |
| Mar 31, 2026 | 28,783.00 |
| Dec 31, 2025 | 27,725.00 |
| Dec 31, 2025 | 27,725.00 |
| Sep 30, 2025 | 26,707.00 |
| Sep 30, 2025 | 26,707.00 |
| Jun 30, 2025 | 199,343.00 |
| Jun 30, 2025 | 199,343.00 |
| Mar 31, 2025 | 64,849.00 |
| Mar 31, 2025 | 64,849.00 |
| Dec 31, 2024 | 62,995.00 |
| Dec 31, 2024 | 62,995.00 |
| Sep 30, 2024 | 61,188.00 |
| Sep 30, 2024 | 61,188.00 |
| Jun 30, 2024 | 59,438.00 |
| Jun 30, 2024 | 59,438.00 |
| Mar 31, 2024 | 57,751.00 |
| Mar 31, 2024 | 57,751.00 |
| Dec 31, 2023 | 56,775.00 |
| Dec 31, 2023 | 56,775.00 |